352 related articles for article (PubMed ID: 25838146)
1. Synthesis and potent inhibitory activities of carboxybenzyl-substituted 8-(3-(R)-aminopiperidin-1-yl)-7-(2-chloro/cyanobenzyl)-3-methyl-3,7-dihydro-purine-2,6-diones as dipeptidyl peptidase IV (DPP-IV) inhibitors.
Mo DW; Dong S; Sun H; Chen JS; Pang JX; Xi BM; Chen WH
Bioorg Med Chem Lett; 2015 May; 25(9):1872-5. PubMed ID: 25838146
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of novel benzyl-substituted (S)-phenylalanine derivatives as potent dipeptidyl peptidase 4 inhibitors.
Liu Y; Si M; Tang L; Shangguan S; Wu H; Li J; Wu P; Ma X; Liu T; Hu Y
Bioorg Med Chem; 2013 Sep; 21(18):5679-87. PubMed ID: 23938053
[TBL] [Abstract][Full Text] [Related]
3. (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors.
Thomas L; Eckhardt M; Langkopf E; Tadayyon M; Himmelsbach F; Mark M
J Pharmacol Exp Ther; 2008 Apr; 325(1):175-82. PubMed ID: 18223196
[TBL] [Abstract][Full Text] [Related]
4. [Design, synthesis and in vitro activity of glycinamide-bearing compounds as DPP-IV inhibitors].
Han B; Huan Y; Lin ZY; Li P; Shen ZF; Yin DL; Huang HH
Yao Xue Xue Bao; 2010 Nov; 45(11):1379-84. PubMed ID: 21361038
[TBL] [Abstract][Full Text] [Related]
5. Discovery of potent dipeptidyl peptidase IV inhibitors through pharmacophore hybridization and hit-to-lead optimization.
Zeng S; Xie H; Zeng LL; Lu X; Zhao X; Zhang GC; Tu ZC; Xu HJ; Yang L; Zhang XQ; Hu W
Bioorg Med Chem; 2013 Apr; 21(7):1749-55. PubMed ID: 23434133
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of thiouracil derivatives as dipeptidyl peptidase IV inhibitors.
Sharma M; Singh D; Gupta M
Chem Biol Drug Des; 2013 Feb; 81(2):257-64. PubMed ID: 23039850
[TBL] [Abstract][Full Text] [Related]
7. Highly potent dipeptidyl peptidase IV inhibitors derived from Alogliptin through pharmacophore hybridization and lead optimization.
Xie H; Zeng L; Zeng S; Lu X; Zhao X; Zhang G; Tu Z; Xu H; Yang L; Zhang X; Wang S; Hu W
Eur J Med Chem; 2013 Oct; 68():312-20. PubMed ID: 23994324
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and pharmacological evaluation of highly potent and selective dipeptidyl peptidase-4 inhibitors.
Jiang T; Zhou Y; Zhu J; Chen Z; Sun P; Zhang Q; Wang Z; Shao Q; Jiang X; Li B; Wang H; Zhu W; Shen J
Arch Pharm (Weinheim); 2015 Jun; 348(6):399-407. PubMed ID: 25871012
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of structurally constrained imidazolidin derivatives as potent dipeptidyl peptidase IV inhibitors.
Wang L; Zhang B; Ji J; Li B; Yan J; Zhang W; Wu Y; Wang X
Eur J Med Chem; 2009 Aug; 44(8):3318-22. PubMed ID: 19375196
[TBL] [Abstract][Full Text] [Related]
10. Discovery of highly potent DPP-4 inhibitors by hybrid compound design based on linagliptin and alogliptin.
Lai ZW; Li C; Liu J; Kong L; Wen X; Sun H
Eur J Med Chem; 2014 Aug; 83():547-60. PubMed ID: 24996141
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Biological Evaluation, and Molecular Docking of (R)-2-((8-(3-aminopiperidin-1-yl)-3-methyl-7-(3-methylbut-2-en-1-yl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)benzonitrile as Dipeptidyl Peptidase IV Inhibitors.
Ran Y; Pei H; Shao M; Chen L
Chem Biol Drug Des; 2016 Feb; 87(2):290-5. PubMed ID: 26426933
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
Patel BD; Bhadada SV; Ghate MD
Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, structure-activity relationships, and docking studies of 1-(γ-1,2,3-triazol substituted prolyl)-(S)-3,3-difluoropyrrolidines as a novel series of potent and selective dipeptidyl peptidase-4 inhibitors.
Zhang L; Su M; Li J; Ji X; Wang J; Li Z; Li J; Liu H
Chem Biol Drug Des; 2013 Feb; 81(2):198-207. PubMed ID: 22994702
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, evaluation and molecular docking of thiazolopyrimidine derivatives as dipeptidyl peptidase IV inhibitors.
Sharma M; Gupta M; Singh D; Kumar M; Kaur P
Chem Biol Drug Des; 2012 Dec; 80(6):918-28. PubMed ID: 22943413
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel pyrimidinedione derivatives as DPP-4 inhibitors.
Li N; Wang LJ; Jiang B; Guo SJ; Li XQ; Chen XC; Luo J; Li C; Wang Y; Shi DY
Bioorg Med Chem Lett; 2018 Jul; 28(12):2131-2135. PubMed ID: 29773502
[TBL] [Abstract][Full Text] [Related]
16. Anagliptin, a potent dipeptidyl peptidase IV inhibitor: its single-crystal structure and enzyme interactions.
Watanabe YS; Yasuda Y; Kojima Y; Okada S; Motoyama T; Takahashi R; Oka M
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):981-8. PubMed ID: 26147347
[TBL] [Abstract][Full Text] [Related]
17. The discovery of novel 5,6,5- and 5,5,6-tricyclic pyrrolidines as potent and selective DPP-4 inhibitors.
Cox JM; Chu HD; Kuethe JT; Gao YD; Scapin G; Eiermann G; He H; Li X; Lyons KA; Metzger J; Petrov A; Wu JK; Xu S; Sinha-Roy R; Weber AE; Biftu T
Bioorg Med Chem Lett; 2016 Jun; 26(11):2622-6. PubMed ID: 27106708
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, biological evaluation, and docking studies of (s)-phenylalanine derivatives with a 2-cyanopyrrolidine moiety as potent dipeptidyl peptidase 4 inhibitors.
Liu Y; Wu Y; Wu H; Tang L; Wu P; Liu T; Hu Y
Chem Biol Drug Des; 2013 Aug; 82(2):140-6. PubMed ID: 23530834
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and discovery of triazolo-pyridazine-6-yl-substituted piperazines as effective anti-diabetic drugs; evaluated over dipeptidyl peptidase-4 inhibition mechanism and insulinotropic activities.
Bindu B; Vijayalakshmi S; Manikandan A
Eur J Med Chem; 2020 Feb; 187():111912. PubMed ID: 31812034
[TBL] [Abstract][Full Text] [Related]
20. Substituted piperidinyl glycinyl 2-cyano-4,5-methano pyrrolidines as potent and stable dipeptidyl peptidase IV inhibitors.
Zhao G; Kwon C; Wang A; Robertson JG; Marcinkeviciene J; Parker RA; Kirby MS; Hamann LG
Bioorg Med Chem Lett; 2013 Mar; 23(6):1622-5. PubMed ID: 23416006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]